MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/ajcp/aqaf154

Медицинская библиотека · American journal of clinical pathology · 2026

Building a diagnostic scoring system for high-grade neuroendocrine neoplasms of the pancreas.

Kinowaki Yuko, Wang Charlotte, Fukumura Yuki, Ganci Maria, Zhang M Lisa, Kobayashi Masanori, Akahoshi Keiichi, Kudo Atsushi, Kinowaki Keiichi, Kai Keita, Mihara Yumi, Murakami Ayumi, Nguyen Hung Ngoc, Hanazawa Ryoichi, Hirakawa Akihiro, Minggao Liang, Kurata Morito, Ishikawa Fumihiko, Castillo Carlos Fernandez-Del, Mino-Kenudson Mari

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVE

High-grade neuroendocrine neoplasms of the pancreas (PanNENs), which comprise well-differentiated pancreatic neuroendocrine tumors, grade 3 (PanNET G3s) and pancreatic neuroendocrine carcinomas (PanNECs), are rare but aggressive tumors. Accurate differentiation between PanNET G3s and PanNECs remains a diagnostic challenge, despite their distinct biological behavior and treatment strategies. This study aimed to develop a scoring system to improve diagnostic accuracy using readily available clinicopathologic and immunohistochemical data.

METHODS

Sixty-six high-grade PanNEN cases underwent clinicopathologic review, immunohistochemistry, and next-generation sequencing. After exclusion of 4 mixed acinar-neuroendocrine carcinomas, 1 diagnostically ambiguous case, and 3 cases with insufficient tissue for next-generation sequencing, 58 cases (29 PanNET G3, 29 PanNEC) were analyzed.

RESULTS

Lasso logistic regression identified predictive features of PanNEC, and multivariable logistic regression was used to assign weights to each factor. Positive predictors of PanNEC included p53 alterations (+4), Rb1 loss (+3), interstitial reaction (+3), co-existing non-neuroendocrine carcinoma (+3), abundant mitoses (+2), and a Ki67 proliferation index greater than 40% (+1). Negative predictors included co-existing PanNET G1/2 (-2), plasmacytoid cells (-1), DAXX/ATRX loss (-1), and somatostatin receptor subtype 2A 3+ (-1). In validation, the average score for PanNEC was 9.52 (median, 10.0); the average score of PanNET G3s was -1.31 (median, -1.0). Using a cutoff of 5.0, the model achieved an area under the curve of 0.989 for distinguishing PanNEC from PanNET G3.

CONCLUSIONS

This novel scoring system demonstrated excellent diagnostic performance in differentiating PanNEC from PanNET by integrating morphologic and immunohistochemical features. Prospective studies with larger cohorts are warranted to validate its clinical utility.

Для цитирования: Kinowaki Yuko, Wang Charlotte, Fukumura Yuki, Ganci Maria, Zhang M Lisa, Kobayashi Masanori, Akahoshi Keiichi, Kudo Atsushi, Kinowaki Keiichi, Kai Keita, Mihara Yumi, Murakami Ayumi, Nguyen Hung Ngoc, Hanazawa Ryoichi, Hirakawa Akihiro, Minggao Liang, Kurata Morito, Ishikawa Fumihiko, Castillo Carlos Fernandez-Del, Mino-Kenudson Mari. Building a diagnostic scoring system for high-grade neuroendocrine neoplasms of the pancreas.. American journal of clinical pathology. 2026. DOI: 10.1093/ajcp/aqaf154.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.